Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Oncostatin M-stimulated apical plasma membrane biogenesis requires p27(Kip1)-regulated cell cycle dynamics.

Van IJzendoorn SC, Théard D, Van Der Wouden JM, Visser W, Wojtal KA, Hoekstra D.

Mol Biol Cell. 2004 Sep;15(9):4105-14. Epub 2004 Jul 7.

3.

Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression.

Halfter H, Friedrich M, Resch A, Kullmann M, Stögbauer F, Ringelstein EB, Hengst L.

Cancer Res. 2006 Jul 1;66(13):6530-9.

4.

Oncostatin M regulates membrane traffic and stimulates bile canalicular membrane biogenesis in HepG2 cells.

van der Wouden JM, van IJzendoorn SC, Hoekstra D.

EMBO J. 2002 Dec 2;21(23):6409-18.

5.

Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway.

Hara T, Kamura T, Nakayama K, Oshikawa K, Hatakeyama S, Nakayama K.

J Biol Chem. 2001 Dec 28;276(52):48937-43. Epub 2001 Oct 26.

7.

The localization and activity of cAMP-dependent protein kinase affect cell cycle progression in thyroid cells.

Feliciello A, Gallo A, Mele E, Porcellini A, Troncone G, Garbi C, Gottesman ME, Avvedimento EV.

J Biol Chem. 2000 Jan 7;275(1):303-11.

8.

Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.

Kortylewski M, Heinrich PC, Mackiewicz A, Schniertshauer U, Klingmüller U, Nakajima K, Hirano T, Horn F, Behrmann I.

Oncogene. 1999 Jun 24;18(25):3742-53.

9.

p27Kip1 regulates T cell proliferation.

Mohapatra S, Agrawal D, Pledger WJ.

J Biol Chem. 2001 Jun 15;276(24):21976-83. Epub 2001 Apr 10.

10.

Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.

Hsieh FF, Barnett LA, Green WF, Freedman K, Matushansky I, Skoultchi AI, Kelley LL.

Blood. 2000 Oct 15;96(8):2746-54.

PMID:
11023508
11.

The p42/p44 mitogen-activated protein kinase activation triggers p27Kip1 degradation independently of CDK2/cyclin E in NIH 3T3 cells.

Delmas C, Manenti S, Boudjelal A, Peyssonnaux C, Eychène A, Darbon JM.

J Biol Chem. 2001 Sep 14;276(37):34958-65. Epub 2001 Jun 19.

12.

Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27(Kip1) association with cyclin E-Cdk2.

Musgrove EA, Hunter LJ, Lee CS, Swarbrick A, Hui R, Sutherland RL.

J Biol Chem. 2001 Dec 14;276(50):47675-83. Epub 2001 Oct 4.

13.

A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression.

Boehm M, Yoshimoto T, Crook MF, Nallamshetty S, True A, Nabel GJ, Nabel EG.

EMBO J. 2002 Jul 1;21(13):3390-401.

14.
15.
16.
17.

Oncostatin M induces growth arrest of skeletal muscle cells in G1 phase by regulating cyclin D1 protein level.

Kim H, Jo C, Jang BG, Oh U, Jo SA.

Cell Signal. 2008 Jan;20(1):120-9. Epub 2007 Oct 3.

PMID:
17976956
18.

BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway.

Gesbert F, Sellers WR, Signoretti S, Loda M, Griffin JD.

J Biol Chem. 2000 Dec 15;275(50):39223-30.

19.

Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle.

Bresnahan WA, Boldogh I, Ma T, Albrecht T, Thompson EA.

Cell Growth Differ. 1996 Oct;7(10):1283-90.

20.

p27(Kip1), a double-edged sword in Shh-mediated medulloblastoma: Tumor accelerator and suppressor.

Bhatia B, Malik A, Fernandez-L A, Kenney AM.

Cell Cycle. 2010 Nov 1;9(21):4307-14. Epub 2010 Nov 27.

Supplemental Content

Support Center